0001193125-05-032012.txt : 20120628 0001193125-05-032012.hdr.sgml : 20120628 20050217160420 ACCESSION NUMBER: 0001193125-05-032012 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20050217 DATE AS OF CHANGE: 20050217 GROUP MEMBERS: DORIT RAVIV SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIO LOGIC SYSTEMS CORP CENTRAL INDEX KEY: 0000355007 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 363025678 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-35477 FILM NUMBER: 05624248 BUSINESS ADDRESS: STREET 1: ONE BIO LOGIC PLZ CITY: MUNDELEIN STATE: IL ZIP: 60060 BUSINESS PHONE: 7089495200 MAIL ADDRESS: STREET 1: ONE BIO LOGIC PLAZA CITY: MUNDELEIN STATE: IL ZIP: 60060 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RAVIV GABRIEL CENTRAL INDEX KEY: 0000902241 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: BUSINESS PHONE: 7089495200 MAIL ADDRESS: STREET 1: ONE BIO LOGIC PLAZA CITY: MUNDELEIN STATE: IL ZIP: 60060 SC 13D 1 dsc13d.htm SCHEDULE 13-D Schedule 13-d

OMB APPROVAL

OMB Number:

  

3235-0145

Expires:

  

December 31, 2005

Estimated average burden

hours per response . . . 15

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

 

 

Under the Securities Exchange Act of 1934

(Amendment No.            )*

 

 

 

 

Bio-logic Systems Corp.

(Name of Issuer)

 

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

 

090909 10 2

(CUSIP Number)

 

 

Gabriel Raviv, Ph.D.

Bio-logic Systems Corp.

One Bio-logic Plaza

Mundelein, IL 60060

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

 

November 4, 2004

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 7


CUSIP No. 090909 10 2

   Page 2 of 7

 

  1.

 

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).

 

Gabriel Raviv

   

  2.

 

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x

(b)  ¨

   

  3.

 

SEC Use Only

 

   

  4.

 

Source of Funds (See Instructions)

 

PF, OO

   

  5.

 

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

   

  6.

 

Citizenship or Place of Organization

 

United States

   
Number of Shares Beneficially Owned by Each Reporting Person With  

  7.    Sole Voting Power

 

        287,4301


  8.    Shared Voting Power

 

        196,939


  9.    Sole Dispositive Power

 

        287,430


10.    Shared Dispositive Power

 

        196,939

11.

 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

694,494

   

12.

 

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

   

1

None of the share and exercise price data contained in this Schedule 13D has been adjusted to reflect the 3-for-2 stock split of the Common Stock effected as a 50 percent stock dividend on February 11, 2005 to stockholders of record as of January 26, 2005.

 

Page 2 of 7


CUSIP No. 090909 10 2

   Page 3 of 7

 

13.

 

Percent of Class Represented by Amount in Row (11)

 

16.34% (based on 4,249,773 shares of Common Stock outstanding as of December 31, 2004).

   

14.

 

Type of Reporting Person (See Instructions)

 

IN

   

  1.

 

Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).

 

Dorit Raviv

   

  2.

 

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  x

(b)  ¨

   

  3.

 

SEC Use Only

 

   

  4.

 

Source of Funds (See Instructions)

 

PF, OO

   

  5.

 

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

   

  6.

 

Citizenship or Place of Organization

 

United States

   
Number of Shares Beneficially Owned by Each Reporting Person With  

  7.    Sole Voting Power

 

        210,125


  8.    Shared Voting Power

 

        196,939


  9.    Sole Dispositive Power

 

        210,125


10.    Shared Dispositive Power

 

        196,939

11.

 

Aggregate Amount Beneficially Owned by Each Reporting Person

 

694,494

   

 

Page 3 of 7


CUSIP No. 090909 10 2

   Page 4 of 7

 

12.

 

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

   

13.

 

Percent of Class Represented by Amount in Row (11)

 

16.34% (based on 4,249,773 shares of Common Stock outstanding as of December 31, 2004).

   

14.

 

Type of Reporting Person (See Instructions)

 

IN

   

 

Item 1.

Security and Issuer

 

The class of securities to which this statement relates is common stock, par value $0.01 per share (the “Common Stock”), of Bio-logic Systems Corp. (the “Issuer”), and the principal executive offices of the Issuer are located at One Bio-logic Plaza, Mundelein, IL 60060.

 

*

None of the share and exercise price data contained in this Schedule 13D has been adjusted to reflect the 3-for-2 stock split of the Common Stock effected as a 50 percent stock dividend on February 11, 2005 to stockholders of record as of January 26, 2005.

 

Item 2.

Identity and Background

 

The identity and background for each person filing this statement and each person enumerated in Instruction C to Schedule 13D is as follows:

 

Name:

  

Gabriel Raviv

Principal Address:

  

c/o Bio-logic Systems Corp.,

One Bio-logic Plaza, Mundelein, IL 60060

Principal Occupation:

  

Chief Executive Officer

Citizenship:

  

United States

Name:

  

Dorit Raviv

Principal Address:

  

c/o Bio-logic Systems Corp.,

One Bio-logic Plaza, Mundelein, IL 60060

Principal Occupation:

  

Clinical Psychologist

Citizenship:

  

United States

 

During the last five years, none of the reporting persons nor any person enumerated in Instruction C to Schedule 13D has been convicted in a criminal proceeding or was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is

 

Page 4 of 7


CUSIP No. 090909 10 2

   Page 5 of 7

 

subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3.

Source and Amount of Funds or Other Consideration

 

The shares of Common Stock held by the Raviv Family Limited Partnership (“RFLP”) were acquired through a gift of shares on November 4, 2004 from the Gabriel Raviv Family Trust (“GRFT”), of which Mimi Lutwak is Trustee, and a gift of 3,939 shares from Gabriel Raviv on December 17, 2004.

 

The sources of funds used to purchase shares of Common Stock directly owned by Gabriel Raviv were personal funds. As of February 14, 2005, Gabriel Raviv can acquire 166,875 shares through the exercise of stock options granted by the Issuer to Gabriel Raviv.

 

Of the shares of Common Stock directly owned by Dorit Raviv, 200,000 shares were acquired through a gift on March 24, 1993 from Gabriel Raviv, which shares he had acquired using personal funds. The remaining 10,125 shares were acquired using personal funds.

 

Item 4.

Purpose of Transaction

 

Gabriel Raviv and Dorit Raviv acquired the shares of Common Stock for general investment purposes. Gabriel Raviv and Dorit Raviv may purchase additional shares of Common Stock in private or open-market transactions for investment purposes, or dispose of shares of Common Stock. Neither Gabriel Raviv nor Dorit Raviv, each in their capacity as an investor in securities of the Issuer, has a plan or proposal with respect to any of the matters set forth in paragraphs (a) through (j) of Item 4 of this Statement.

 

Item 5.

Interest in Securities of the Issuer

 

(a)

As of February 14, 2005, Gabriel Raviv and Dorit Raviv beneficially own 694,494 shares of Common Stock, which represent 16.34% of the 4,249,773 shares of Common Stock outstanding as of December 31, 2004. Of the shares beneficially owned by Gabriel Raviv and Dorit Raviv, they beneficially own (i) 214,305 shares of Common Stock held by Gabriel Raviv directly, over which he has sole voting and dispositive power, and which Dorit Raviv is deemed to beneficially own pursuant to Rule 13d-5(b)(1) under the Securities Exchange Act of 1934, as amended (the “Act”), (ii) 196,939 shares of Common Stock held by RFLP, over which Gabriel Raviv and Dorit Raviv have shared voting and dispositive control as the sole general partners, (iii) 210,125 shares of Common Stock held by Dorit Raviv directly, over which she has sole voting and dispositive power, and which Gabriel Raviv is deemed to beneficially own pursuant to Rule 13d-5(b)(1) under the Act, (iv) 30,000 shares of Common Stock held by the Gil Raviv Family Trust, of which Gabriel Raviv is trustee and has sole voting and dispositive control, and which Dorit Raviv is deemed to beneficially own pursuant to Rule 13d-5(b)(1) under the Act, and (v) 43,125 shares of Common Stock underlying options exercisable within 60 days over which Gabriel Raviv has sole voting and dispositive power and which Dorit Raviv is deemed to beneficially own pursuant to Rule 13d-5(b)(1) under the Act.

 

Page 5 of 7


CUSIP No. 090909 10 2

   Page 6 of 7

 

(b)

As of February 14, 2005:

 

Gabriel Raviv has sole power to vote and to dispose of 287,430 shares of Common Stock, and shared power with Dorit Raviv to vote and dispose of 196,939 shares of Common Stock.

 

Dorit Raviv has sole power to vote and to dispose of 210,125 shares of Common Stock, and shared power with Gabriel Raviv to vote and to dispose of 196,939 shares of Common Stock.

 

(c)

On November 4, 2004, the Gabriel Raviv Family Trust, of which Mimi Lutwak is Trustee, gifted 193,000 shares of Common Stock to RFLP. On December 17, 2004, Gabriel Raviv gifted 3,939 shares of Common Stock to RFLP. On January 11, 2005, Gabriel Raviv exercised options to purchase 2,500 shares of Common Stock at an exercise price of $5.13 per share, 1,875 shares of Common Stock at an exercise price of $5.58 per share and 26,250 shares of Common Stock at an exercise price of $4.95 per share, and delivered to the Company 15,926 shares of Common Stock as payment of the aggregate exercise price therefor.

 

(d)

As of February 14, 2005, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock.

 

(e)

Not applicable.

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

In March 2004, the Issuer entered into an employment agreement with Gabriel Raviv (the “Raviv Agreement”) (see Exhibit 1 hereto). The Raviv Agreement is for an initial term of four years and is renewable for successive two-year terms thereafter, and provides for salary, benefits and bonuses determined at the discretion of the Issuer’s Board of Directors. The Raviv Agreement also provides that Gabriel Raviv is eligible to receive stock awards under the Issuer’s 1994 Stock Option Plan, as amended (the “1994 Stock Option Plan”), or such other stock plan or equity incentive plan adopted by the Issuer and in effect from time to time. Any such stock awards will be made at the discretion of the administrator of such stock plan and the awards shall be subject to the terms of the plan and the applicable award agreement.

 

As of February 14, 2005, Gabriel Raviv holds options to acquire an aggregate of (a) 119,375 shares of Common Stock granted under the 1994 Stock Option Plan (see Exhibit 2 hereto), and (b) 47,500 shares of Common Stock granted under the Issuer’s 2004 Stock Incentive Plan (the “2004 Stock Incentive Plan”) (see Exhibit 4 hereto). All such options were granted pursuant to stock option agreements entered into by Gabriel Raviv (see Exhibit 3 for grants made under the 1994 Stock Option Plan, and Exhibits 5 and 6 for grants made under the 2004 Stock Incentive Plan). The material terms of Gabriel Raviv’s options outstanding as of February 14, 2005 are set forth in the table below.

 

Page 6 of 7


CUSIP No. 090909 10 2

   Page 7 of 7

 

Number of Underlying Shares

   Exercisable (1)

   Exercise Price

   Grant Date

   Expiration Date

  

Name of Equity Incentive Plan


8,750    0    4.95    6/5/2001    6/5/2006    1994 Stock Option Plan
625    0    5.577    8/23/2001    8/23/2006    1994 Stock Option Plan
60,000    30,000    4.84    7/10/2002    7/10/2007    1994 Stock Option Plan
2,500    1,250    4.73    8/22/2002    8/22/2007    1994 Stock Option Plan
45,000    11,250    5.42    8/25/2003    8/25/2008    1994 Stock Option Plan
2,500    625    5.42    8/25/2003    8/25/2008    1994 Stock Option Plan
45,000    0    6.44    7/22/2004    7/22/2009    2004 Stock Incentive Plan
2,500    0    6.44    7/22/2004    7/22/2009    2004 Stock Incentive Plan

 

(1)

All options vest in four equal annual installments commencing one year from the grant date.

 

On December 1, 2001, Gabriel Raviv and Dorit Raviv (collectively, the “General Partners”) entered into a limited partnership agreement (the “Partnership Agreement”) (see Exhibit 7 hereto) with each of the General Partners’ three children, Ronnie Raviv, Tal Raviv and Jonathan Raviv (collectively, the “Limited Partners” and together with the General Partners, the “Partners”), providing for the formation of the Raviv Family Limited Partnership, an Illinois limited partnership (the “Partnership”), the object and purpose of which is to acquire, own, manage and dispose of investment assets. All decisions regarding the management and operations of the business and property of the Partnership are made by Gabriel Raviv as managing general partner. On October 16, 2003, the General Partners and the Limited Partners entered into the First Amendment to the Partnership Agreement (see Exhibit 7 hereto) to provide for mandatory, additional capital contributions by the Partners upon the receipt of notice from the General Partners regarding the same.

 

Item 7.

Material to Be Filed as Exhibits

 

 

1.

Employment Agreement by and between the Issuer and Gabriel Raviv, dated as of March 1, 2004 (incorporated by reference to Exhibit 10.3 to the Issuer’s Annual Report on Form 10-K for the fiscal year ended February 29, 2004).

 

 

2.

1994 Stock Option Plan, as amended (incorporated by reference to Exhibit 10.15 to the Issuer’s Registration Statement on Form S-8 as filed with the Securities and Exchange Commission (the “Commission”) on September 17, 1997 (Registration No. 333-35773)).

 

 

3.

Form of Incentive Stock Option Agreement under the 1994 Stock Option Plan, as amended.

 

 

4.

Bio-Logic Systems Corp. 2004 Stock Incentive Plan (incorporated by reference to Exhibit 4.5 to the Issuer’s Registration Statement on Form S-8 as filed with the Commission on September 20, 2004 (Registration No. 333-119115) (the “2004 Registration Statement”)).

 

 

5.

Form of Non-Qualified Stock Option Agreement under the Bio-logic Systems Corp. 2004 Stock Incentive Plan (incorporated by reference to Exhibit 4.6 to the 2004 Registration Statement).

 

 

6.

Form of Incentive Stock Option Agreement under the Bio-logic Systems Corp. 2004 Stock Incentive Plan (incorporated by reference to Exhibit 4.7 to the 2004 Registration Statement).

 

 

7.

Limited Partnership Agreement of the Raviv Family Limited Partnership by and among Gabriel Raviv, Dorit Raviv, Ronnie Raviv, Tal Raviv and Jonathan Raviv, dated December 1, 2001 (the “Partnership Agreement”), and the First Amendment to the Partnership Agreement dated October 16, 2003.

 

 

8.

Powers of Attorney to Michael J. Hanley and Roderick G. Johnson from Gabriel Raviv, dated February 11, 2005.

 

 

9.

Powers of Attorney to Gabriel Raviv, Roderick G. Johnson and Michael J. Hanley from Dorit Raviv, dated February 11, 2005.

 

Page 7 of 7


Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date:

February 15, 2005

 

/s/ Michael J. Hanley, as Attorney-in-Fact

Gabriel Raviv

 


 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date:

February 15, 2005

 

/s/ Michael J. Hanley, as Attorney-in-Fact

Dorit Raviv

 

EX-3 2 dex3.htm INCENTIVE STOCK OPTION AGREEMENT Incentive Stock Option Agreement

Exhibit 3

 

«First» «Last»

 

NOTE: The completion of this document may necessitate the filing of SEC Form 3 and SEC Form 4 with the Securities and Exchange Commission. Bio-logic Corp. attorneys will need to be notified if these forms are to be completed.

 

Optionee: «First» «Last»

 

BIO-LOGIC SYSTEMS CORP.

 

1994 STOCK OPTION PLAN

 

INCENTIVE STOCK OPTION AGREEMENT

 

OPTION AGREEMENT dated                     ,              between BIO-LOGIC SYSTEMS CORP., a Delaware corporation (the “Company”), and <<FirstName>> <<LastName>> (the “Optionee”).

 

The Company has adopted the 1994 Stock Option Plan (the “Plan”) and desires to grant to the Optionee the Incentive Stock Option provided for herein, all subject to the terms and conditions of the Plan. Capitalized terms used herein and not defined have the same meanings as set forth in the Plan.

 

IT IS AGREED as follows:

 

1. Grant of Option. The Company hereby grants to the Optionee on the date hereof the right and option to purchase (subject to adjustment pursuant to Section 15 of the Plan) an aggregate of «words» («F_03_Grants») of its shares of Common Stock (“Common Stock”) at an option price per share equal to $            .

 

2. Option Period. The option granted hereby shall expire on the tenth anniversary of the date hereof, subject to earlier termination as provided in the Plan.

 

3. Exercise of Option.

 

 

A.

The Optionee may exercise the option hereby granted in whole or in part from and after the dates set forth below:

 

Number of Shares

  

Initial Exercise Date

«Vesting»

  

«Vesting»

«Vesting»

  

«Vesting»

 


«Vesting»

  

«Vesting»

«Vesting»

  

«Vesting»

 

 

B.

The Optionee may exercise the option (to the extent then exercisable) by delivering to the Company a written notice duly signed by the Optionee stating the number of shares that the Optionee has elected to purchase and accompanied by (i) payment (in cash or by certified check) of an amount equal to the full purchase price for the shares to be purchased, (ii) by delivery to the Company of shares of Common Stock of the Company having a Fair Market Value on the date of exercise equal in amount to the exercise price of the options being exercised or (iii) any other method of payment provided for in the Plan to which the Stock Option Committee of the Company’s Board of Directors may consent. “Fair Market Value” of a share of Common Stock of the Company as of a specified date for the purposes of the Plan shall mean the closing price of a share of the Common Stock on the principal securities exchange on which such shares are traded on the day immediately preceding the date as of which Fair Market Value is being determined, or on the next preceding date on which such shares are traded if no shares were traded on such immediately preceding day, or if the shares are not traded on a securities exchange, Fair Market Value shall be deemed to be average of the high bid and low asked prices of the shares on the over-the-counter market on the day immediately preceding the date as of which Fair Market Value is being determined or on the next preceding date on which such high bid and low asked prices were recorded. If the shares are not publicly traded, Fair Market Value of a share of Common Stock (including, in the case of any repurchase of shares, any distributions with respect thereto which would be repurchased with the shares) shall be determined in good faith by the Board of Directors. In no case shall Fair Market Value be determined with regard to restrictions other than restrictions which, by their terms, will never lapse. Within twenty days after receipt by the Company of such notice and payment, the Company shall issue the shares in the name of the Optionee and deliver the certificate therefore to the Optionee. No shares shall be issued until full payment therefore has been made, and the Optionee shall have none of the rights of a shareholder in respect of such shares until they are issued.

 

4. Termination. Nothing contained in this Option Agreement shall confer upon the Optionee any right to remain an employee of the Company. If the Optionee’s position with the Company is terminated for any reason, this option shall be exercisable only as to those shares immediately purchasable by Optionee at the date of termination and, subject to Section 2 hereof, only for a period of three months after the termination, or one year in the case of death or disability.

 

5. Non-Transferability of Option. This option shall not be transferable other than by will or by the laws of descent and distribution, and may be exercised during the Optionee’s lifetime only by Optionee.

 

6. Tax Status. The option hereby granted is intended to qualify as an incentive stock option within the meaning of Section 422A of the Code, provided, however, to the extent that the aggregate fair market value as of the date of this grant, of the shares into which this option becomes exercisable for the first time by the Optionee during the calendar year exceeds $100,000, the portion of this option which is in excess of the $100,000 limitation will be treated as a non-statutory stock option.

 


7. Incorporation of Plan. The option granted hereby is subject to, and governed by, all the terms and conditions of the Plan, which are hereby incorporated by reference. This Agreement, including the Plan incorporated by reference herein, is the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings. In the case of any conflict between the terms of this agreement and the Plan, the provisions of the Plan shall control.

 

8. Purchase for Investment. As a condition to the exercise in whole or in part of the option hereby granted, each written notice of election shall include a representation by the Optionee that the shares are being purchased for investment and not for distribution or resale.

 

9. Notices. Any notice to be given by the Optionee hereunder shall be sent to the Company at its principal executive offices, and any notice from the Company to the Optionee shall be sent to the Optionee at Optionee’s address set forth above, all such notices shall be in writing and shall be delivered in person or by registered or certified mail. Either party may change the address to which notices are to be sent by notice in writing given to the other in accordance with the terms hereof.

 

10. Governing Law. The parties hereto hereby acknowledge and agree that the option granted hereby is granted in the State of New York and any shares issued upon exercise of the option will be used in the State of New York. This Agreement, as well as the grant of such option and issuance of such shares, is and shall be governed by and construed in accordance with the laws of the State of New York applicable to the agreements made and to be performed entirely with such State.

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.

 

BIO-LOGIC SYSTEMS CORP.

By

   
 

«First» «Last», Optionee

 


 

Bio-logic Systems Corp.

Irrevocable Incentive Stock Option Exercise Form

 

This is an irrevocable purchase of stock. Please complete this form and deliver both the form, and a cashier’s check for the Grand Total of your purchase made payable to the Bio-logic Systems Corp., to the Accounting Department. Please have your cashier put your name in the memo portion of the check

 

Grant Date


  

Shares
Granted


  

# Shares Being Exercised


  

Exercise
(Purchase)
Cost


  

Total Amount
Due


                     
                     
                     

 

Grand Total $                    

 

Certificate Issuance. Please issue a certificate pursuant to this option exercise as follows:

 

___

In my name alone.

 

___

In my name and in the name of                                                                                           , as joint tenants.

 

Important Note: One of the characteristics associated with an Incentive Stock Option agreement is that you do not pay income taxes on the difference between your purchase price of the stock and the current market price of the stock when you purchase the stock; any applicable taxes are owed only at the time that you sell it. However, to maintain this favorable tax treatment, you are required to hold the stock and not sell it until the later of (1) one year after the completion of this option exercise (your purchase date); or (2) two years after the grant date of the options. It may not be to your advantage from a tax standpoint to sell your stock before this holding period is over. Please consult your tax advisor for more information.

 

Signature and Mailing Information

        
           

Signature of Optionee

     

Date

           

Printed or Typed Name

     

Street Address

           

Social Security Number

     

City, State, ZIP

 

EX-7 3 dex7.htm LIMITED PARTNERSHIP AGREEMENT Limited Partnership Agreement

Exhibit 7

 

LIMITED PARTNERSHIP AGREEMENT

 

OF

 

THE RAVIV FAMILY LIMITED PARTNERSHIP

 

THIS LIMITED PARTNERSHIP AGREEMENT (this “Agreement”) is made and entered into effective for all purposes and in all respects as of the 1st day of December, 2001, by and among GABRIEL RAVIV and DORIT RAVIV (the “General Partners”) and GABRIEL RAVIV, DORIT RAVIV, RONNIE RAVIV, TAL RAVIV and JONATHAN RAVIV (collectively, the “Limited Partners”); together with the General Partners, (collectively the “Partners”).

 

1. Formation and Name of the Partnership. The Partners hereby form a limited partnership (hereinafter referred to as the “Partnership”) pursuant to the provisions of the Partnership Law of the State of Illinois, upon the terms, covenants and conditions hereinafter set forth. The name of the Partnership shall be THE RAVIV FAMILY LIMITED PARTNERSHIP.

 

2. Principal Office. The principal place of business of the Partnership shall be 1048 Woodlawn Rd., Glenview, IL 60025, or at such other place as may from time to time be approved by the General Partners.

 

3. Name and Address of the Partners. The name, address and percentage of interest in the Partnership (“Interest”) of each Partner is set forth in Exhibit A attached hereto and made a part hereof.

 

4. Term of the Partnership. The Partnership shall terminate as provided in this Agreement.

 


5. Purposes and Powers of the Partnership.

 

A. The object and purpose of the Partnership shall be to acquire, own, manage and dispose of investment assets.

 

B. The Partnership may execute, deliver and perform all contracts and undertakings and engage in any and all activities and transactions as may in the determination of the General Partners be necessary or advisable to carry out the foregoing objects and purposes.

 

6. Capital Contributions. Each Partner shall contribute to the capital of the Partnership the amount set forth after such Partner’s name on Exhibit A.

 

A. Prior to the dissolution and liquidation of the Partnership, no Partner shall be entitled to withdraw any part of such Partner’s capital contribution, except as provided in Paragraph C of this Article, and except that distributions made in accordance with the Distributions Article of this instrument may represent in whole or in part a return of capital.

 

B. No Partner shall have the right to demand the return of such Partner’s capital contribution at any time except as provided below in Paragraph C of this Article, and except that distribution made in accordance with the Article entitled Distributions may represent in whole or in part a return of capital.

 

C. Immediately following each capital gift (as defined below), the Partner whose capital account is gratuitously increased by this capital gift (hereinafter referred to as a Donee Partner) may withdraw the increase in his or her capital account occasioned by this capital gift, subject to the limitations, rules and procedures set forth below.

 

(1) The maximum amount that a Donee Partner may withdraw with respect to all capital gifts made by the same donor in any calendar year shall not, in any event, exceed the gift tax annual exclusion in effect at the time of each capital gift, less the amount of prior gifts to the same Donee Partner either outright or in trust, by the same

 

2


donor during the same calendar year, which gifts were eligible for the federal gift tax annual exclusion but not eligible for the federal gift tax marital or charitable deductions.

 

(2) All gifts to a Donee Partner that enter into the computation under this Section shall, absent an express direction to the contrary by a donor at or before the time of a capital gift, be treated as having been made equally by the donor and the donor’s spouse, if the donor was married when the gift was made, and the gift was eligible for gift-splitting under Code Sec. 2513(a). The limitation under Subparagraph 1 of this Paragraph C with respect to capital gifts made by a donor who was married when the capital gift was made and which gift was eligible for gift-splitting under Code Sec. 2513, shall be separately calculated and applied as to each spouse’s deemed half of the gift.

 

(3) The withdrawal right of a Donee Partner shall lapse on the date sixty (60) days after the date of the capital gift to which it relates, regardless of whether that date falls within the same calendar year as that in which the capital gift was made.

 

(4) The General Partners shall promptly notify each competent adult Donee Partner of all capital gifts to which that Donee Partner’s withdrawal right relates. The General Partners shall notify a Partner who is under a legal disability (including minority) (hereafter sometimes referred to as a “disabled Donee Partner”), by notifying:

 

(i) the legal guardian of the individual’s property, who is hereby authorized to exercise the withdrawal rights;

 

(ii) any living parent of the individual;

 

(iii) any other person taking care of the individual or with whom the individual resides; or

 

3


(iv) any other adult individual whom the General Partners shall deem appropriate.

 

(5) Withdrawal rights under this Section shall be exercisable by a writing delivered to the General Partners. The person to whom notice is properly given for a disabled Donee Partner may decide whether to exercise that disabled Donee Partner’s withdrawal right, unless that person receiving notice is the donor of the contribution to which the withdrawal right relates, in which case the General Partners shall designate another appropriate adult individual to make such decision.

 

(6) The General Partners may, by an instrument in writing executed at or before a capital gift, exclude one or more Donee Partners from having withdrawal rights over that capital gift or any future capital gift or both. The General Partners may not, however, limit or alter any rights resulting from prior capital gifts.

 

(7) Notwithstanding any other provision of this Agreement, the General Partners may make no distributions of capital or income of the Partnership that would reduce the available Partnership capital below the total amount of the then-existing withdrawal rights without advance notice to each Partner who is entitled to make a withdrawal or who is, under this Article, entitled to act for a disabled Donee Partner.

 

(8) “Capital gift” means any transfer, to the extent, if any, that it constitutes a gift for Federal gift tax purposes, of a Partnership Interest to a donee who is or thereafter becomes a Partner with respect to that transferred interest, and any contribution to the capital of the Partnership if that contribution gratuitously increases the capital account of another Partner (the Donee Partner with respect to such capital gift).

 

(9) If the General Partners shall incorrectly determine the amount that should be distributed to a Donee Partner under this Section, then within a reasonable

 

4


period after the correct amount is finally determined, the General Partners shall receive from the Donee Partner or shall pay to the Donee Partner, as the case may be, an amount equal to the difference between the amount that could properly have been withdrawn and the amount actually withdrawn.

 

(10) All withdrawal rights to which this Section apply shall arise immediately upon each capital gift.

 

(11) The General Partners may without liability assume that no prior gifts to any holder of a withdrawal right under this Section were made by a donor or a donor’s spouse other than capital gifts, unless the General Partners shall have actual notice to the contrary.

 

7. Accounting Matters and Financial Reports. The Partnership shall keep or cause to be kept full and faithful books of account reflecting all of the Partnership’s activities and transactions. The books of account shall be maintained at the principal place of business of the Partnership. The Partnership shall use the calendar year as its fiscal year, unless otherwise determined by the General Partners. The Partnership’s books and records shall be kept in accordance with the accrual method of accounting for income tax and other reporting purposes, unless otherwise determined by the General Partners. Annual statements, including a statement of the Partnership’s profits and losses for the fiscal year, shall be prepared by the General Partners and distributed to each Partner within a reasonable time after the close of each fiscal year.

 

8. Management.

 

A. Except as otherwise provided herein, all decisions regarding the management and operations of the business and property of the Partnership shall be made by Gabriel Raviv as Managing General Partner.

 

5


B. GABRIEL RAVIV shall be the Tax Matters Partner of the Partnership as provided in Section 6231 of the Internal Revenue Code of 1986, as amended.

 

C. The Partnership shall indemnify each General Partner and each withdrawn General Partner against any cost, expense (including legal or other expenses reasonably incurred in investigation or defense), judgment or liability, joint or several, incurred without gross negligence or bad faith on the part of such General Partner or withdrawn General Partner in connection with any claim, action, suit or proceeding to which such General Partner or withdrawn General Partner may be made a party or otherwise involved or with which such General Partner or withdrawn General Partner shall be threatened, arising out of or in connection with such General Partner or withdrawn General Partner’s activities or involvement with the Partnership.

 

9. Assignment of a Partner’s Interest. A Partner may sell, assign, transfer, encumber, hypothecate or otherwise dispose of all or any part of such Partner’s Partnership Interest, or such Partner’s equitable right to the profits or capital of the Partnership, either with the prior written consent of the General Partners, which consent may be withheld in the General Partners’ sole and absolute discretion, or pursuant to a bona fide offer (as defined below), as to which no such consent shall be required (but which shall be subject to the right of first refusal set forth in the succeeding paragraph). A person who acquires a Partner’s interest in a transfer that does not comply with this Section shall be an assignee and shall neither become a Partner nor vote or participate in any decision of the Partners.

 

A. A Partner may sell, assign, or otherwise transfer any of his or her Partnership Interest in exchange for valuable consideration (in whole or in part), only pursuant to a bona fide offer (as defined below), and a Partner who receives and wishes to accept a bona fide offer to buy any or all of his or her Partnership Interest shall promptly send a notice to each other

 

6


Partner and be deemed to have offered to sell that portion of his or her Partnership Interests to which the bona fide offer relates, to the other Partners at the same price and on the same terms as those in the bona fide offer. This notice shall include a statement of the name, address (both home and office), and business or occupation of the person to whom such Partnership Interest would be sold, the price at which and the terms on which the Partner proposes to sell his or her Partnership Interest pursuant to the bona fide offer, and any other facts that would reasonably be deemed material.

 

B. Each other Partner shall have sixty (60) days from the date on which the notice referred to in this Article is mailed by U.S. mail, or if earlier, the date on which it is personally delivered to each other Partner, in which to elect to buy all or any of the offered interests (as defined below). Each other Partner may accept this offer and elect to buy the offered interests in proportion to their respective percentages of the total Partnership Interests (excluding the offered interests), or in such other proportion as they shall agree upon.

 

C. If the other Partners do not agree to buy in the aggregate all of the offered interests within this option period, the offered interests may be sold pursuant to the bona fide offer. If the offered interests are not sold pursuant to the bona fide offer within thirty (30) days after the expiration of the option period, the restrictions on transfer under this Agreement shall again apply as if no bona fide offer had been received and no notice had been given. A sale of the offered interest is consummated when notice is received by the General Partners that ownership of the offered interests has been transferred.

 

D. For purposes of this Article, a bona fide offer shall mean a written offer received from a prospective buyer who reasonably appears to be financially able to complete the purchase, setting forth in detail the purchase price and terms under which the offered interests will be bought, together with a good check equal to at least Ten Percent (10%) of the proposed

 

7


purchase price. For purposes of this Article, the “offered interests” shall mean all of the Partnership Interests to which a bona fide offer refers.

 

10. Death, Legal Incapacity or Bankruptcy of a General Partner.

 

A. Upon the death or legal incapacity of a General Partner, or in the event that a General Partner shall make a general assignment for the benefit of creditors, be adjudicated a bankrupt or insolvent or file a voluntary petition in bankruptcy, or in the event there is an order for relief entered against a General Partner under the Federal Bankruptcy Code of 1978, as amended (or a similar order under a successor statute), if (i) the remaining General Partner or General Partners, if any, elect to continue the Partnership business, or (ii) all of the Limited Partners agree, within ninety (90) days after the happening of such event, to continue the Partnership, and if there is no other General Partner, elect one (1) or more persons to be a General Partner or General Partners of the Partnership, then the Partnership shall not dissolve.

 

B. Upon the occurrence of any of the events set forth in the previous paragraph, the General Partner with respect to whom such event occurred shall forthwith cease to have any rights or powers to participate in the management and operation of the Partnership business and such General Partner’s vote shall not be counted in connection with any decision made by the General Partners hereunder or in determining whether the unanimous vote of the General Partners has been obtained. If any such event shall occur with respect to a General Partner, the executor, trustee, personal representative, successors, heirs or beneficiaries of such General Partner shall be bound by all obligations of such General Partner under this Agreement and, except as provided in the preceding sentence, shall succeed to all rights of such General Partner.

 

11. Profits and Losses. Except to the extent required by the Regulations issued under Code Sec. 704(b) with respect to deductions attributable to debt as to which a Partner has the risk

 

8


of loss (and offsetting income), all items of income, gain, loss, deduction and credit of the Partnership for each fiscal year of the Partnership shall be allocated among the Partners in the same proportion as their respective Partnership Interests.

 

12. Distributions. Distributions shall be made from cash (or non-cash assets determined by the General Partners) available to the Partnership as determined by the General Partners. Distributions shall be made to the Partners in accordance with their respective Partnership Interests.

 

13. Dissolution and Winding Up of the Partnership.

 

A. The Partnership shall dissolve and be wound up upon the occurrence of any of the following events:

 

(1) The occurrence of any event set forth in the first paragraph of the Section entitled “Death, Legal Incapacity or Bankruptcy of a General Partner” above, unless the Partnership is continued as provided in that paragraph.

 

(2) The Partners, by unanimous agreement, shall elect, in writing, to dissolve the Partnership.

 

B. Upon the occurrence of any of the events described in the Article entitled “Dissolution and Winding Up of Partnership” above, the General Partners, or such other person as may be authorized by law, shall, as soon as practicable, wind up the affairs of the Partnership and distribute the assets of the Partnership. The assets of the Partnership shall be used and/or distributed in the following order and priority:

 

(1) First, to pay liabilities to creditors of the Partnership, in the order of priority, as provided by law, except liabilities to Partners on account of their capital contributions and any loans made by partners to the Partnership;

 

9


(2) Second, to pay the debts and liabilities of the Partnership to any Partner as the result of any loan by such Partner to the Partnership;

 

(3) Thereafter, to pay any balance remaining to the Partners in proportion to their respective Partnership Interests.

 

C. The Partnership shall terminate when all assets of the Partnership have been sold and/or distributed and all affairs of the Partnership have been wound up.

 

14. Notices. All notices to be given hereunder to any Partner shall be in writing and shall be sent to the address of such Partner as set forth in Exhibit A attached hereto. Each Partner may change the address to which notices to such Partner shall be sent by giving the Partnership written notice of the new address. Any notice to be given hereunder to the Partnership shall be in writing and addressed to the principal office of the Partnership, and shall be hand delivered or sent by registered or certified mail, postage prepaid, return receipt requested.

 

15. Amendments. This Agreement may be amended or modified only by a written instrument approved in writing by all of the Partners.

 

16. Binding Nature of Agreement. The provisions of this Agreement shall be binding upon the executors, administrators, legal representatives, heirs, successors and assigns of the parties hereto.

 

17. General Provisions.

 

A. This Agreement may be executed in counterparts, each one of which shall be deemed an original and all the counterparts together shall constitute one and the same Agreement.

 

B. The headings and captions herein are inserted solely for the purpose of convenience of reference and are not a part of and are not intended to govern, limit or aid in the construction of any term or provision hereof.

 

10


C. If any term or provision of this Agreement or the application thereof to any person or circumstance shall to any extent be invalid or unenforceable, the remainder hereof and the application of such term or provision to persons or circumstances other than those to which it is held invalid or unenforceable shall not be affected thereby.

 

D. This Agreement and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of the State of Illinois.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

 

GENERAL PARTNERS:

/s/ Gabriel Raviv

GABRIEL RAVIV

/s/ Dorit Raviv

DORIT RAVIV

LIMITED PARTNERS:

/s/ Gabriel Raviv

GABRIEL RAVIV

/s/ Dorit Raviv

DORIT RAVIV

/s/ Ronnie Raviv

RONNIE RAVIV

/s/ Tal Raviv

TAL RAVIV

/s/ Jonathan Raviv

JONATHAN RAVIV

 

11


 

FIRST AMENDMENT

TO

LIMITED PARTNERSHIP AGREEMENT

OF

THE RAVIV FAMILY LIMITED PARTNERSHIP

 

THIS FIRST AMENDMENT dated this 16th day of October, 2003 is to a Limited Partnership Agreement (the “Agreement”) originally made and entered into as of the 1st day of December, 2001, by and among Gabriel Raviv and Dorit Raviv (the “General Partners”) and Ronnie Raviv, Tal Raviv and Jonathan Raviv (collectively, the “Limited Partners”); together with the General Partners (collectively the “Partners”).

 

WHEREAS, since the date of the Agreement, the Partners have made their respective initial contributions to the capital of the Partnership and desire to amend Exhibit A in order to reflect their respective Partnership Contributions and Partnership Interests resulting from said contributions to capital; and

 

WHEREAS, Partners may desire to contribute additional capital to the Partnership from time to time and desire to provide guidelines in the Agreement as to the effect such additional contributions shall have upon the Partnership Interests.

 

NOW THEREFORE, in consideration of the foregoing and mutual covenants hereinafter set forth, the Partners agree as follows:

 

FIRST:

  

The Partners’ contributions to the capital of the Partnership and Partnership Interests are set forth opposite each Partner’s name and address on the Amended Exhibit A to the Partnership Agreement attached hereto and made a part of the Agreement.

SECOND:

  

The following new Paragraph D shall be added to Section 6 of the Agreement immediately following Paragraph C of Section 6, as follows:

    

“D. If the General Partners determine that the Partners shall contribute additional capital (“Additional Capital”) to the Partnership, the General Partners shall notify the Partners of the amount of the contribution of Additional Capital and the time within which each Partner shall contribute the Partner’s share of the Additional Capital. Each Partner shall contribute such Partner’s share of Additional Capital equal to the total Additional Capital to be contributed to the Partnership from time to time multiplied by such Partner’s percentage of Partnership Interest as set forth on the Exhibit A attached to the Agreement, as last amended. If any Partner refuses or fails to make such Partner’s share of Additional Capital within the time specified on any such notice, the General Partners shall have the power to reduce the noncontributing Partner’s Partnership Interest in relation to the contributing Partners, by such percentage deemed reasonable by the General Partners in order to fairly reflect the Partnership Interests of all the Partners based upon their aggregate contributions to the

 


    

capital of the Partnership, taking into consideration the underlying value of the Partnership assets at the time of such refusal or failure.”

THIRD:

  

In all other respects, the Agreement as hereby amended, is ratified and affirmed.

 

IN WITNESS THEREOF, the Partners have executed this First Amendment to the Agreement as of the day and year first above written.

 

GENERAL PARTNERS:

     

LIMITED PARTNERS:

/s/ Gabriel Raviv

     

/s/ Ronnie Raviv

Gabriel Raviv

     

Ronnie Raviv

/s/ Dorit Raviv

     

/s/ Tal Raviv

Dorit Raviv

     

Tal Raviv

        

/s/ Jonathan Raviv

       

Jonathan Raviv

 

2

EX-8 4 dex8.htm POWER OF ATTORNEY Power of Attorney

Exhibit 8

 

POWER OF ATTORNEY

 

The undersigned hereby constitutes and appoints Michael J. Hanley and Roderick G. Johnson, and each of them, as the undersigned’s true and lawful authorized representatives and attorneys-in-fact to execute for and on behalf of the undersigned and to file with the United States Securities and Exchange Commission and any other authority: (a) any Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13(d) of the 1934 Act and the rules promulgated thereunder.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, hereby ratifying and confirming all that each such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 or any other provision of the 1934 Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Form 3, 4 or 5 or any Schedule 13D or 13G, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of February 11, 2005.

 

/s/ Gabriel Raviv

Gabriel Raviv

 

EX-9 5 dex9.htm POWER OF ATTORNEY Power of Attorney

Exhibit 9

 

POWER OF ATTORNEY

 

The undersigned hereby constitutes and appoints Gabriel Raviv, Roderick G. Johnson and Michael J. Hanley, and each of them, as the undersigned’s true and lawful authorized representatives and attorneys-in-fact to execute for and on behalf of the undersigned and to file with the United States Securities and Exchange Commission and any other authority: (a) any Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13(d) of the 1934 Act and the rules promulgated thereunder.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, hereby ratifying and confirming all that each such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 16 or Section 13 or any other provision of the 1934 Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Form 3, 4 or 5 or any Schedule 13D or 13G, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of February 11, 2005.

 

/s/ Dorit Raviv

Dorit Raviv